124 related articles for article (PubMed ID: 30912026)
1. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
[TBL] [Abstract][Full Text] [Related]
2. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
Marín-Jiménez JA; Capasso A; Lewis MS; Bagby SM; Hartman SJ; Shulman J; Navarro NM; Yu H; Rivard CJ; Wang X; Barkow JC; Geng D; Kar A; Yingst A; Tufa DM; Dolan JT; Blatchford PJ; Freed BM; Torres RM; Davila E; Slansky JE; Pelanda R; Eckhardt SG; Messersmith WA; Diamond JR; Lieu CH; Verneris MR; Wang JH; Kiseljak-Vassiliades K; Pitts TM; Lang J
Front Immunol; 2021; 12():607282. PubMed ID: 33854497
[TBL] [Abstract][Full Text] [Related]
3. Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors.
Lanis JM; Lewis MS; Strassburger H; Larsen K; Bagby SM; Dominguez ATA; Marín-Jiménez JA; Pelanda R; Pitts TM; Lang J
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591990
[TBL] [Abstract][Full Text] [Related]
4. Autologous reconstitution of human cancer and immune system in vivo.
Fu J; Sen R; Masica DL; Karchin R; Pardoll D; Walter V; Hayes DN; Chung CH; Kim YJ
Oncotarget; 2017 Jan; 8(2):2053-2068. PubMed ID: 28008146
[TBL] [Abstract][Full Text] [Related]
5. Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment.
Chiorazzi M; Martinek J; Krasnick B; Zheng Y; Robbins KJ; Qu R; Kaufmann G; Skidmore Z; Juric M; Henze LA; Brösecke F; Adonyi A; Zhao J; Shan L; Sefik E; Mudd J; Bi Y; Goedegebuure SP; Griffith M; Griffith O; Oyedeji A; Fertuzinhos S; Garcia-Milian R; Boffa D; Detterbeck F; Dhanasopon A; Blasberg J; Judson B; Gettinger S; Politi K; Kluger Y; Palucka K; Fields RC; Flavell RA
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37487666
[TBL] [Abstract][Full Text] [Related]
6. Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity.
Steinkamp MP; Lagutina I; Brayer KJ; Schultz F; Burke D; Pankratz VS; Adams SF; Hudson LG; Ness SA; Wandinger-Ness A
Cancer Res Commun; 2023 Feb; 3(2):309-324. PubMed ID: 36860657
[TBL] [Abstract][Full Text] [Related]
7. Potential Perturbations of Critical Cancer-regulatory Genes in Triple-Negative Breast Cancer Cells Within the Humanized Microenvironment of Patient-derived Xenograft Models.
Her Y; Yun J; Son HY; Heo W; Kim JI; Moon HG
J Breast Cancer; 2024 Feb; 27(1):37-53. PubMed ID: 38233337
[TBL] [Abstract][Full Text] [Related]
8. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.
Evrard YA; Srivastava A; Randjelovic J; Doroshow JH; Dean DA; Morris JS; Chuang JH;
Cancer Res; 2020 Jun; 80(11):2286-2297. PubMed ID: 32152150
[TBL] [Abstract][Full Text] [Related]
9. Humanized mouse models for anti-cancer therapy.
Baietti MF; Leucci E
Methods Cell Biol; 2024; 183():317-333. PubMed ID: 38548416
[TBL] [Abstract][Full Text] [Related]
10. Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma.
Yan C; Nebhan CA; Saleh N; Shattuck-Brandt R; Chen SC; Ayers GD; Weiss V; Richmond A; Vilgelm AE
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509357
[TBL] [Abstract][Full Text] [Related]
11. Innovations, challenges, and minimal information for standardization of humanized mice.
Stripecke R; Münz C; Schuringa JJ; Bissig KD; Soper B; Meeham T; Yao LC; Di Santo JP; Brehm M; Rodriguez E; Wege AK; Bonnet D; Guionaud S; Howard KE; Kitchen S; Klein F; Saeb-Parsy K; Sam J; Sharma AD; Trumpp A; Trusolino L; Bult C; Shultz L
EMBO Mol Med; 2020 Jul; 12(7):e8662. PubMed ID: 32578942
[TBL] [Abstract][Full Text] [Related]
12. Humanized mouse models for immuno-oncology research.
Chuprin J; Buettner H; Seedhom MO; Greiner DL; Keck JG; Ishikawa F; Shultz LD; Brehm MA
Nat Rev Clin Oncol; 2023 Mar; 20(3):192-206. PubMed ID: 36635480
[TBL] [Abstract][Full Text] [Related]
13. Humanized mice for immune checkpoint blockade in human solid tumors.
Yip H; Haupt C; Maresh G; Zhang X; Li L
Am J Clin Exp Urol; 2019; 7(5):313-320. PubMed ID: 31763362
[TBL] [Abstract][Full Text] [Related]
14. Adult immune compromised zebrafish for xenograft cell transplantation studies.
Yan C; Yang Q; Do D; Brunson DC; Langenau DM
EBioMedicine; 2019 Sep; 47():24-26. PubMed ID: 31416720
[No Abstract] [Full Text] [Related]
15. Phenotyping of Macrophages in Human Immune System Mice.
Voss L; Reitinger C; Lux A
Methods Mol Biol; 2024; 2713():117-128. PubMed ID: 37639118
[TBL] [Abstract][Full Text] [Related]
16. Local irradiation of patient-derived tumors in immunodeficient mice.
van der Zalm AP; Bootsma S; Rodermond HM; Oei AL; Bijlsma MF
STAR Protoc; 2023 Mar; 4(1):102098. PubMed ID: 36825807
[TBL] [Abstract][Full Text] [Related]
17. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
Okada S; Vaeteewoottacharn K; Kariya R
Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
19. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Brendel C; Rio P; Verhoeyen E
Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
